限售股上市流通

Search documents
宝立食品: 国泰海通证券股份有限公司关于上海宝立食品科技股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-07-09 16:25
Core Viewpoint - The report outlines the verification opinions regarding the listing and circulation of restricted shares for Shanghai Baoli Food Technology Co., Ltd. following its initial public offering (IPO) [1][10]. Group 1: Listing of Restricted Shares - The restricted shares being listed are from the initial public offering, with a total of 241,200,000 shares set to be released on July 15, 2025 [2][9]. - The total number of shares issued during the IPO was 40,010,000 shares, with the company’s total share capital remaining unchanged since the IPO [2][9]. Group 2: Shareholder Commitments - Shareholders, including Hangzhou Zhenpin Zhixin Investment Partnership, Ma Ju, Hangzhou Baoyu Investment Management Partnership, and Yang Xueqin, have committed to not transferring or managing their pre-IPO shares for 36 months from the IPO date [3][4][5]. - If the stock price falls below the IPO price for 20 consecutive trading days within the first six months, the lock-up period will automatically extend by an additional six months [3][4][5]. Group 3: Compliance and Verification - As of the date of the verification opinion, all shareholders have strictly adhered to their commitments regarding the lock-up of shares, with no violations affecting the listing of restricted shares [8][9]. - The sponsor institution confirms that the listing and circulation of restricted shares comply with relevant regulations and that the information disclosure is accurate and complete [10].
皓元医药: 上海皓元医药股份有限公司关于发行股份及支付现金购买资产并募集配套资金暨关联交易之部分限售股上市流通公告
Zheng Quan Zhi Xing· 2025-07-08 09:13
Core Viewpoint - The announcement details the listing and circulation of restricted shares related to the acquisition of assets by Shanghai Haoyuan Pharmaceutical Co., Ltd, with a total of 4,493,210 shares set to be listed on July 16, 2025 [1][9]. Summary by Sections Listing of Restricted Shares - The company will list 4,493,210 restricted shares, which were issued to specific investors for asset acquisition and fundraising [1][2]. - The shares were registered on December 22, 2022, following approval from the China Securities Regulatory Commission [2]. Changes in Share Capital - Following the issuance of shares, the total share capital of the company increased from 104,078,810 shares to 106,982,272 shares [2]. - The company’s total share capital further increased to 150,217,339 shares after a capital increase of 0.40 shares per existing share was approved [3]. Performance Compensation - The shareholders involved in the asset acquisition, including WANG YUAN and others, are required to fulfill performance compensation obligations due to unmet performance commitments by the acquired company [6][8]. - A total of 47,725 shares were repurchased and canceled as part of the performance compensation process, reducing the total share capital to 211,561,848 shares [7]. Compliance and Verification - The independent financial advisor confirmed that the shareholders have adhered to their commitments regarding the lock-up period and performance compensation [8][9]. - The listing of the restricted shares complies with relevant regulations and the company’s disclosure is deemed accurate and complete [9]. Details of the Restricted Shares - The total number of restricted shares being listed represents 2.12% of the company's total share capital as of July 7, 2025 [10].
昊华化工科技集团股份有限公司关于2025年度6月对外担保的进展公告
Shang Hai Zheng Quan Bao· 2025-07-02 18:33
Group 1 - The company announced a guarantee of RMB 14.7 million for its subsidiary Jiangxi Hetian Technology Co., Ltd. [5][11] - As of the announcement date, the total guarantee amount provided by the company to Jiangxi Hetian is RMB 32.35 million [5][11] - The guarantee was approved at the company's 2024 annual general meeting [3][4] Group 2 - The guarantee is backed by Jiaxing Heli Equity Investment Partnership [2] - The guarantee agreement was signed on June 28, 2025, with a guarantee period from June 18, 2025, to June 17, 2026 [10] - The guarantee is intended to support the working capital needs of the subsidiary [11] Group 3 - The company has a total guarantee amount of RMB 1.29 billion, which is 7.37% of the latest audited net assets [13] - The company has no overdue guarantees [4][14] - The company has not provided guarantees to controlling shareholders or related parties [14] Group 4 - The company is set to list 161,290,322 shares for trading on July 8, 2025, as part of a non-public offering [17][18] - The total number of shares after the issuance will be 1,290,033,705 [19] - The issuance was approved by the China Securities Regulatory Commission on June 20, 2024, for a maximum of RMB 4.5 billion [18]
奥比中光: 中国国际金融股份有限公司关于奥比中光首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-27 16:10
Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares from the initial public offering (IPO) of Obsidian Technology Group Co., Ltd. The restricted shares amount to 34,032,240 shares, representing 8.48% of the company's total share capital, and will be available for trading starting July 7, 2025 [1][6][10]. Summary by Sections 1. Type of Restricted Shares - The restricted shares are part of the IPO approved by the China Securities Regulatory Commission on April 22, 2022, with a total of 40,001,000 shares issued. The total share capital after the IPO is 400,001,000 shares, with 7.74% being restricted shares [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, the company's total share capital has increased to 400,001,000 shares, with no other changes due to profit distribution or capital reserve transfers [4][5]. 3. Commitments Related to Restricted Shares - The shareholders of the restricted shares have committed not to transfer or manage their shares for three years post-IPO. They can only reduce their holdings by a maximum of 2% of the total shares in the fourth and fifth fiscal years after the IPO [5][10]. 4. Verification of Commitments - As of the date of the verification opinion, the shareholders have strictly adhered to their commitments, and there are no issues affecting the listing of the restricted shares [6][10]. 5. Details of Restricted Shares - The total number of restricted shares to be listed is 34,032,240, which constitutes 8.48% of the total share capital. The listing date for these shares is set for July 7, 2025 [6][8][10].
凌云光: 中国国际金融股份有限公司关于凌云光技术股份有限公司首次公开发行部分限售股上市流通暨承诺不减持事项的核查意见
Zheng Quan Zhi Xing· 2025-06-24 17:01
Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares of Lingyun Optical Technology Co., Ltd. after its initial public offering, emphasizing compliance with relevant regulations and the commitment of shareholders not to reduce their holdings for a specified period [1][10]. Group 1: Restricted Shares Listing - The restricted shares being listed for circulation total 223,777,585 shares, representing 48.5442% of the company's total share capital [9]. - The listing date for these restricted shares is set for July 7, 2025, as July 6, 2025, is a non-trading day [9]. - The total number of shares issued during the initial public offering was 10,350,000, with a total share capital of 463,500,000 shares post-IPO [1]. Group 2: Changes in Share Capital - Following the repurchase and cancellation of 2,523,267 shares, the company's total share capital decreased from 463,500,000 shares to 460,976,733 shares [2]. - No other events have occurred that would affect the number of shares since the formation of the restricted shares [2]. Group 3: Shareholder Commitments - Shareholders have committed not to transfer or reduce their holdings of restricted shares for 36 months from the date of the IPO [3][4]. - If the share price falls below the IPO price, the lock-up period will automatically extend by at least 6 months [3]. - The controlling shareholders have voluntarily committed not to transfer or reduce their holdings for 12 months following the lifting of the lock-up period on July 7, 2025 [9]. Group 4: Compliance and Verification - The verification opinion confirms that the company has adhered to the relevant laws and regulations regarding the listing of restricted shares [10]. - The report states that the information disclosed by Lingyun Optical regarding the restricted shares is true, accurate, and complete [10].
青云科技: 中国国际金融股份有限公司关于北京青云科技集团股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-23 12:16
Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares for Beijing Qingyun Technology Group Co., Ltd. after its initial public offering on the Sci-Tech Innovation Board [1][10]. Group 1: Listing of Restricted Shares - The restricted shares being listed are part of the company's initial public offering, totaling 11,855,468 shares, which accounts for 24.8024% of the company's total share capital [2][10]. - The shares will be available for circulation starting from July 1, 2025, after a lock-up period of three full accounting years plus an additional six months [2][12]. Group 2: Changes in Share Capital - Following the initial public offering, the company's total share capital increased from 47,462,175 shares to 47,785,987 shares due to the vesting of restricted stock options [2]. - The total share capital will further increase to 47,799,688 shares after the second vesting period of the restricted stock options in 2024 [2]. Group 3: Commitments from Shareholders - Shareholders have committed to not transferring or managing their shares for 36 months post-listing, with specific conditions for reducing their holdings thereafter [3][6]. - The commitments include conditions on share price and operational status of the company, ensuring that any reduction in holdings does not significantly disrupt the market [7][9]. Group 4: Compliance and Verification - The verification opinion confirms that the listing of restricted shares complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [10]. - The report indicates that all shareholders have adhered to their commitments, and there are no issues affecting the listing of the restricted shares [10].
中无人机: 中无人机首次公开发行部分限售股上市流通公告
Zheng Quan Zhi Xing· 2025-06-20 13:26
Core Viewpoint - The announcement details the upcoming listing and circulation of restricted shares for AVIC Chengdu UAV Systems Co., Ltd., with a total of 403,378,057 shares set to be released on June 30, 2025, marking a significant event in the company's stock market activity [1][9]. Summary by Sections 1. Listing of Restricted Shares - The shares being listed are part of the company's initial public offering (IPO) and involve 8 shareholders, representing 59.76% of the total share capital [2][10]. - The total number of shares after the IPO is 675,000,000, with 121,794,229 shares being unrestricted and 553,205,771 shares being restricted [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2]. 3. Commitments Related to Restricted Shares - Shareholders and the actual controller, AVIC, have committed not to transfer or manage the shares for 36 months from the date of listing [2][3]. - If the stock price falls below the issue price for 20 consecutive trading days within the first 6 months, the lock-up period will automatically extend by 6 months [3][4]. 4. Compliance and Verification - As of the announcement date, the shareholders have adhered to their commitments, ensuring no issues that would affect the listing of the restricted shares [9]. - The underwriting institutions, CITIC Securities and AVIC Securities, have confirmed that the listing complies with relevant regulations and commitments [9][10]. 5. Details of Restricted Shares - The total number of restricted shares being listed is 403,378,057, which will transition from restricted to unrestricted status on the specified date [10]. - The breakdown of shareholders holding these restricted shares includes various entities under AVIC, ensuring a concentrated ownership structure [10].
春立医疗: 华泰联合证券有限责任公司关于北京市春立正达医疗器械股份有限公司首次公开发行部分限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-19 10:01
Core Viewpoint - The report from Huatai United Securities provides a thorough review of the listing and circulation of restricted shares for Beijing Chunli Zhengda Medical Devices Co., Ltd., confirming compliance with relevant regulations and the fulfillment of commitments by shareholders [1][8]. Group 1: Restricted Shares Overview - The restricted shares being listed for circulation are part of the company's initial public offering, involving two shareholders: Mr. Shi Chunbao and Ms. Yue Shujun. The original lock-up period of 36 months has been extended by 6 months due to the fulfillment of commitment conditions, now set to end on June 30, 2025 [2][6]. - The total number of restricted shares being released is 209,133,335, which accounts for 54.52% of the company's total share capital [6][8]. Group 2: Changes in Share Capital - The company's total share capital has changed from 384,280,000 shares to 383,568,500 shares since the formation of the restricted shares [2][4]. Group 3: Shareholder Commitments - Shareholders have made several commitments regarding their restricted shares, including not proposing buybacks and extending the lock-up period if the stock price falls below the IPO price for a specified duration [4][5]. - As of the date of the announcement, the shareholders have adhered to their commitments, ensuring no issues affecting the listing of restricted shares [5][8]. Group 4: Regulatory Compliance - Huatai United Securities has confirmed that the listing and circulation of the restricted shares comply with various regulatory frameworks, including the Securities Issuance and Listing Sponsorship Business Management Measures and the Shanghai Stock Exchange's rules [1][8].
京城股份: 京城股份发行股份及支付现金购买资产并募集配套资金之部分限售股上市流通的公告
Zheng Quan Zhi Xing· 2025-06-17 11:11
Core Points - The announcement details the listing of restricted shares for Beijing Jingcheng Machinery Electric Company Limited, with a total of 7,034,552 shares set to be publicly traded starting June 24, 2025 [1][5][21] - The shares are part of a non-public issuance related to the acquisition of assets and the raising of supporting funds, approved by the China Securities Regulatory Commission [1][2] - The total number of restricted shares issued for asset acquisition amounts to 46,481,314 shares, with specific lock-up periods for different shareholders [2][3] Share Registration and Lock-up Arrangements - The newly issued shares are subject to a 12-month lock-up period for certain shareholders, after which they will be released in stages based on performance compensation agreements [2][8] - The first phase of unlocking allows for 40% of the shares to be released after the 12-month period, contingent on fulfilling performance obligations for 2021 [2][10] - Subsequent phases will release 20% of shares based on the completion of performance obligations for 2022 and 2023 [2][10] Changes in Share Capital - Following the completion of the non-public issuance, the total share capital of the company increased from 485,000,000 shares to 531,481,314 shares, with 109,481,314 shares classified as restricted [4][6] - The company’s total share capital as of the announcement date is 547,665,988 shares, with 19,469,105 shares under restricted conditions [7][8] Compliance and Verification - The independent financial advisor, CITIC Securities, confirmed that the listing of restricted shares complies with relevant laws and regulations, and that there are no violations affecting the listing [21] - The company has committed to adhering to all regulatory requirements and ensuring the independence of its operations post-transaction [16][19]
智翔金泰: 国泰海通证券股份有限公司关于重庆智翔金泰生物制药股份有限公司首次公开发行战略配售限售股上市流通的核查意见
Zheng Quan Zhi Xing· 2025-06-12 14:09
Core Viewpoint - The report outlines the verification opinions regarding the listing and circulation of strategic placement restricted shares of Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. following its initial public offering on the Sci-Tech Innovation Board [1][5]. Summary by Sections 1. Type of Restricted Shares - The company issued 91,680,000 shares during its IPO, with a total share capital of 366,680,000 shares post-IPO. The restricted shares amount to 2,639,915 shares, representing 0.7200% of the total share capital, with a lock-up period of 24 months starting from June 20, 2023 [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, there have been no changes in the company's share capital due to profit distribution or capital reserve transfers [2]. 3. Commitments Related to Restricted Shares - The shareholder, Haitong Innovation Securities Investment Co., Ltd., has committed to a lock-up period of 24 months from the IPO date. After the lock-up period, any reduction in shareholding will comply with the relevant regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange [2][3]. 4. Listing and Circulation of Restricted Shares - The restricted shares will be listed and available for circulation on June 20, 2025. The total number of shares for circulation is 2,639,915, which is the entire amount of strategic placement shares [3][4]. 5. Verification Opinions from the Sponsor - The sponsor, Guotai Junan Securities Co., Ltd., confirms that all commitments made by the restricted share shareholders have been strictly adhered to, and the listing and circulation of the restricted shares comply with relevant regulations [4][5].